How to lose a billion pounds: Editorial

International Journal of Clinical Practice

Volumn 61, Issue 1, 2007, Pages 2-3

  Moon, James C ^a   Bogle, Richard G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; LOSARTAN; MACROLIDE; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; SEROTONIN 3 ANTAGONIST; SIMVASTATIN; TRIPTAN DERIVATIVE;

BUDGET; CARDIOVASCULAR DISEASE; COST CONTROL; DRUG CLASSIFICATION; DRUG COST; DRUG SUBSTITUTION; EDITORIAL; FERMENTATION; GENERAL PRACTITIONER; HEALTH CARE; HUMAN; NATIONAL HEALTH SERVICE; POPULATION DISTRIBUTION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE PRICING; SCALE UP; UNITED KINGDOM;

ANTILIPEMIC AGENTS; BUDGETS; COST SAVINGS; DRUG COSTS; DRUGS, GENERIC; GREAT BRITAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; STATE MEDICINE;

EID: 33847012584     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01221.x     Document Type: Editorial

References (5)

1. Usher-Smith JA, Ramsbottom T, Pearmain H, Kirby M. Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting. Int J Clin Pract 2007; 61: 15-23.
2. Prescription Cost Analysis, 2005. http://www.ic.nhs.uk/pubs/ prescostanalysis2005 (accessed October 2006).
3. The NHS Electronic Drug Tariff. http://www.ppa.org.uk (accessed October 2006).
4. Moon JC, Bogle RG. Switching statins (Editorial). BMJ 2006; 332: 1344-5.
5. Aaserud M, Dahlgren AT, Kösters JP, Oxman AD, Ramsay C, Sturm H. Pharmaceutical Policies: Effects of Reference Pricing, Other Pricing, and Purchasing Policies (Cochrane Review). The Cochrane Database of Systematic Reviews 2006, Issue 2 and available at http://www.update-software.com/Abstracts/ ab005979.htm.